Sandeepa Satya-sriram Mullady M.D.

Recommended Articles

• Muscular Dystrophy: Combining Brain-Computer Interfaces and Assistive Technologies

  With the development of modern computers and networks, assistive technologies (AT) for people with disabilities have changed a lot. Not only can one control the devices through the voice, indeed, most of the devices and appliances can be connected to the voice activation services. So one can change...

• Childhood Alzheimer's Patient Dies due to Accident in Hospice Care

  Mark and Lisa Bushaway, both 48 years old and living in the UK, grieve the loss of their 21-year-old daughter Emily due to Neimann-Pick Type C, otherwise known as childhood Alzheimer's, and are devastated to learn their younger daughter Sarah also has the genetic disorder.“With one, you think you...

• Dodgers’ Closer Kenley Jansen Helps Pay for Multiple Sclerosis Medical Treatment for Teenager

  Closer for the Dodgers, Kenley Jansen, was the savior for several of the team’s games. Now, Jansen has jumped at the opportunity to help a man in dire need of medical treatment that he cannot afford. ...

• How Questionnaires Can Affect Multiple Sclerosis Survival Rates

  Questionnaires are valuable tools for diagnosing many disorders. They can find symptoms to trace and help doctors connect the dots to a diagnosis. As a patient, you want to give the most accurate answers to your doctor. With multiple sclerosis, it may be hard to tell which symptoms are related....

• Deep Brain Stimulation Surgery Improves Quality of Life for Parkinson's Patient

  Parkinson’s Disease Disrupts the Life of a Single DadMuscle spasms, stiffness, and decreased motor skills are not symptoms commonly associated with younger people in their 20s and 30s. For Bill Swayze, however, these symptoms appeared and resulted in early diagnosis of Parkinson’s at the rare...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...